Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Doximity, Inc. (DOCS)

Then, on April 1, 2024, Jehoshaphat Research published a report alleging, among other things, that "Doximity's underlying sales . . . are declining at a negative 3-6% rate, but that this decline has been masked through accelerated revenue recognition." On this news, Doximity's stock price fell $1.11, or 4.1$25.80 per share on April 2, 2024, thereby injuring investors further. The complaint filed in this class action alleges that throughout the Class Period, D ...